SCHEMBL2180058

SCHEMBL2180058

CCN(CC)CCNC(=O)c1ccc(-c2nnc3c(n2)c(=O)n(C)c(=O)n3Cc2cccnc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.45
GAA P10253 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
NAMPT P43490 2/20 0.42
RAD52 P43351 1/20 0.41
MAPT P10636 1/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
GLA P06280 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182494 0.95 MAPT (0.46) TP53GAAHSD17B10ALDH1A1HPGD
SCHEMBL2180406 0.89 NAMPT (0.42) GAAHSD17B10ALDH1A1HPGDNAMPT
SCHEMBL2179287 0.88 HIF1A (0.40) ALDH1A1HPGDMAPTMAPK1
SCHEMBL2181258 0.85 HIF1A (0.39) ALDH1A1HPGDMAPTKMT2AMAPK1
SCHEMBL3264999 0.84 KMT2A (0.42) TP53GAAHSD17B10ALDH1A1HPGD
SCHEMBL2180850 0.84 GRIN1 (0.40) ALDH1A1HTTMAPT
SCHEMBL2183832 0.84 PLD2 (0.46) TP53GAAHSD17B10ALDH1A1HPGD
SCHEMBL2182780 0.84 GRIN1 (0.40) ALDH1A1HTTMAPT
SCHEMBL2179558 0.84 MAPT (0.43) TP53GAAHSD17B10ALDH1A1HPGD
SCHEMBL2183775 0.83 ADORA2A (0.46) ALDH1A1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR TP53 64/4885GAA 1134/4885HSD17B10 962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.